ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma

Qu, Shanqiang*; Liu, Jin; Wang, Huafu*南方医科大学; 6
Frontiers in Immunology2021-4-6DOI: 10.3389/fimmu.2021.648416
15被引5阅读
引用收藏
分享

摘要

Background @@@ Previous research indicated that the tumor cells and microenvironment interactions are critical for the immunotherapeutic response. However, predicting the clinical response to immunotherapy remains a dilemma for clinicians. Hence, this study aimed to investigate the associations between EVA1B expression and prognosis and tumor-infiltrating immune cells in glioma. @@@ Methods @@@ Firstly, we detected the EVA1B expression in glioma tissues through biological databases. The chi-squared test, Kaplan-Meier, and univariate and multivariate Cox regression analyses were used to analyze the clinical significance of EVA1B expression. The correlation between EVA1B expression and levels of tumor-infiltrating immune cells in glioma tissues was investigated. Receiver operating characteristic (ROC) analysis was performed to compare the predictive power between EVA1B and other commonly immune-related markers. @@@ Results @@@ In the CGGA cohort of 325 glioma patients, we found that EVA1B was upregulated in glioma, and increased with tumor grade. High EVA1B expression was prominently associated with unfavorable clinicopathological features, and poorer survival of patients, which were further confirmed by TCGA (n=609) and GEO (n=74) cohorts. Furthermore, multivariate analysis indicated that EVA1B is an independent prognostic biomarker for glioma. Importantly, EVA1B overexpression was associated with a higher infiltration level of CD4(+) T cells, CD8(+) T cells, B cells, macrophages, and neutrophils in glioma. ROC curves showed that, compared with PD-L1, CTLA-4, and Siglec15, EVA1B presented a higher area under the curve (AUC) value (AUC=0.824) for predicting high immune infiltration levels in glioma. @@@ Conclusions @@@ We found that EVA1B was upregulated and could act as a poor prognostic biomarker in glioma. Importantly, EVA1B overexpression was associated with the immune infiltration levels of immune cells including B cells, CD4(+) T cells, CD8(+) T cells, macrophages, and neutrophils, and strongly with the overall immune infiltration levels of glioma. These findings suggested that EVA1B might be a potential biomarker for evaluating prognosis and immune infiltration in glioma.

学科与关键词

关键词
EVA1Bprognosisgliomabiomarkermicroenvironment
相关
加载中…
  • EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma
    Hu, Zhicheng; Qu, Shanqiang*Frontiers in Immunology, 2021, 12: 683572.被引 15
  • GDF15 expression in glioma is associated with malignant progression, immune microenvironment, and serves as a prognostic factor
    Guo, Longbin; Chen, Yulei; Hu, Shushu; Gao, Lianxuan; Tang, Nan; Liu, Rongping; Qin, Yue; Ren, Chen*; Du, Shasha*CNS Neuroscience & Therapeutics, 2022, 28(1): 158-171.被引 9
  • Comprehensive Analysis of Expression and Prognostic Value of MS4As in Glioma
    Zeng, Yingying; Tan, Peixin; Ren, Chen; Gao, Lianxuan; Chen, Yulei; Hu, Shushu; Tang, Nan; Chen, Chen; Du, Shasha*Frontiers in Genetics, 2022, 13: 795844.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2021-04-06
卷期
第 12 卷
页码
648416
DOI
10.3389/fimmu.2021.648416
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE

作者

  • Q

    Qu, Shanqiang (通讯) (第一作者)

    southern med univ

  • L

    Liu, Jin

    6 · wenzhou med univ

查看全部 3 位作者收起作者
  • W

    Wang, Huafu (通讯)

    6 · wenzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417